sophocarpine has been researched along with Liver Steatosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, SW; Chen, YX; Hu, PF; Ning, BF; Shi, J; Song, CY; Xie, WF; Zeng, X; Zheng, ZW | 1 |
Chen, YX; Shi, J; Song, CY; Xie, WF; Zeng, X; Zhang, Y | 1 |
2 other study(ies) available for sophocarpine and Liver Steatosis
Article | Year |
---|---|
Sophocarpine alleviates non-alcoholic steatohepatitis in rats.
Topics: Adipokines; Alkaloids; Animals; Anti-Inflammatory Agents; Cytokines; Cytoprotection; Disease Models, Animal; Down-Regulation; Fatty Liver; Inflammation Mediators; Lipids; Liver; Male; Non-alcoholic Fatty Liver Disease; Organ Size; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Time Factors; Transaminases | 2011 |
Sophocarpine alleviates hepatocyte steatosis through activating AMPK signaling pathway.
Topics: Adipokines; Adiponectin; Alkaloids; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Cell Survival; Cells, Cultured; Fatty Liver; Hepatocytes; Male; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley; Signal Transduction | 2013 |